Traditional Chinese medicinal composition for treating lymphomas

Abstract

The invention discloses a traditional Chinese medicinal composition for treating lymphomas. The traditional Chinese medicinal composition comprises, by weight, 10-30 parts of prepared rehmannia roots, 10-20 parts of edible tulips, 10-20 parts of oysters, 5-15 parts of moutan bark, 10-20 parts of selfheal, 10-20 parts of Chinese violets, 10-20 parts of caulis fici pumilae, 5-15 parts of rhizomes of paniculate bolbostemma, 10-20 parts of oldenlandia diffusa, 10-20 parts of semen cuscutae, 5-15 parts of felwort, 10-20 parts of semen plantaginis, 10-20 parts of kelp, 10-20 parts of honeysuckle stems, 5-15 parts of ligusticum wallichii, 10-20 parts of codonopsis pilosula, 10-20 parts of radix isatidis, 5-15 parts of caulis akebiae, 10-20 parts of air potatoes, 10-20 parts of eclipta, 5-15 parts of rhizoma sparganii, 10-20 parts of radix scrophulariae, 10-20 parts of sealwort and 5-15 parts of licorice roots. The traditional Chinese medicinal composition has the effect of tonifying liver and kidney, enriching blood, promoting blood circulation, clearing away heat and toxic materials, tonifying qi and removing stagnation, and has remarkable curative effect on the lymphomas and reliable action.

Description

technical field [0001] The invention relates to a medical preparation of undetermined structure of traditional herbal medicine, especially a traditional Chinese medicine composition for treating lymphoma. Background technique [0002] Lymphoma is a malignant tumor originating from the lymphatic hematopoietic system. It is mainly manifested as painless lymphadenopathy, hepatosplenomegaly, and various tissues and organs of the whole body can be involved, accompanied by systemic symptoms such as fever, night sweats, weight loss, and itching. With the in-depth development of lymphoma research, great progress has been made in its pathological diagnosis, classification, staging, treatment methods and residual disease diagnostic scoring, which has a great impact on the cure rate of lymphoma. significance. At present, the relatively new drugs for the treatment of lymphoma mainly include rituximab, bortezomib, and 131I-tositumomab. The initial treatment is effective for most patien...

AI Technical Summary

Problems solved by technology

The initial treatment is effective for most patients, but they often relapse, and long-term use is prone to durability, aggravating the development of the disease